Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2198 of 5804
-
New hope for pouchitis sufferers: experimental drug enters trial
Disease control TerminatedThis clinical trial is to evaluate investigational compound CLF065 as a treatment for adult patients with chronic pouchitis. The goals are to establish the safety, feasibility and efficacy of weekly dosing of long acting CLF065 versus placebo.
Phase: PHASE2 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Brain leak clue to chronic fatigue and long COVID brain fog?
Knowledge-focused ENROLLING_BY_INVITATIONMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex chronic illness impacting multiple body systems and characterized by activity-limiting fatigue and post exertional symptom exacerbation, affecting over 3.5 million adults in the US and as many as half of tho…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Could a daily supplement of 'Good' bacteria help prevent another heart attack?
Disease control Not yet recruitingAcute coronary syndrome (ACS) remains one of the leading causes of morbidity and mortality worldwide despite major advances in acute management and secondary prevention. Gut dysbiosis has been described as linked to cardiovascular events. Modulating the gut microbiota through sym…
Phase: NA • Sponsor: Centre Hospitalier de Bienne • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Bar staff as violence preventers: new study tests safety program
Prevention Not yet recruitingThe goal of this project is to evaluate the effectiveness of Safe Night Out, a community-level primary violence prevention program offered in drinking establishments in the Sacramento region of California. The main questions this project aims to answer are: 1) Does the Safe Night…
Sponsor: University of California, San Diego • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
Pilates from home: a new hope for MS symptoms?
Symptom relief Not yet recruitingObjectives Objective 1: To determine the effects of a 16-week remotely delivered Pilates intervention on walking endurance, walking speed, balance, fatigue, and pain compared to a waitlist control group in individuals with MS. Objective 2: To examine the impact of a 16-week remo…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to keep new moms Opioid-Free after C-Section
Symptom relief Not yet recruitingThe goal of this clinical trial is to determine whether suzetrigine increases the proportion of patients who remain completely opioid-free from completion of surgery through 72 hours after cesarean delivery. The main question it aims to answer is: Does adjunctive suzetrigine, w…
Phase: PHASE4 • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Can a video call with a coach help inmates beat addiction?
Disease control Not yet recruitingThe goal of this study is to learn whether a virtual peer recovery coach (PRC) intervention can improve engagement in addiction treatment among incarcerated adults with substance use disorders. The main questions it aims to answer are: * Does the PRC intervention increase engag…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could your own fat heal burn scars? new study investigates
Symptom relief Not yet recruitingThis study aims to evaluate the effectiveness of nano-fat grafting in treating hypertrophic scars caused by burns on the chest, shoulders, and back. Burn scars in these specific areas are often difficult to treat because the skin is under constant tension and motion, which can p…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New drug combo aims to tame blood vessel inflammation
Disease control Not yet recruitingThe purpose of this study is to determine whether a treatment with 3 months of bosentan associated to standard therapy might be superior to glucocorticoids alone in term of failure free survival at 12 months
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a blood pressure pill help heart failure patients get the meds they need?
Disease control Not yet recruitingThe evidence-based pharmacologic treatments available for patients with heart failure with reduced ejection fraction (HFrEF) has been established over the last few decades of cardiovascular research. These treatments, termed Foundational Guideline-Directed-Medical Therapies (GDMT…
Phase: PHASE2, PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Knee surgery pain relief: could a simple nerve block cut opioid use?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether a preoperative genicular nerve block (GNB) can reduce pain after knee replacement surgery in adults with knee osteoarthritis (OA) undergoing total knee arthroplasty (TKA). It will also assess whether this treatment can reduce op…
Phase: NA • Sponsor: Helse Møre og Romsdal HF • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Friendly visitors may boost stroke recovery at home
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are: 1. After 3 months of being discharged from the hospital, does th…
Phase: NA • Sponsor: Bruyère Health Research Institute. • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New inhaler combo could slow lung decline in smokers at risk of COPD
Disease control Not yet recruitingPreserved Ratio Impaired Spirometry (PRISm) is characterized by a normal forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio but an FEV1 below 80% of the predicted value. It has a population prevalence of approximately 10% and is associated with marked…
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a light helmet ease lewy body dementia?
Symptom relief Not yet recruitingDementia with Lewy bodies (DLB) is a neurodegenerative disease diagnosed primarily based on the presence of cognitive decline, which may include difficulties with memory, attention, and more. Additionally, at least two of the following symptoms are needed for a probable diagnosis…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New treadmill trick may help stroke patients walk evenly again
Knowledge-focused Not yet recruitingStroke is a leading cause of long-term disability in adults. Although many individuals regain independent walking ability following stroke, nearly 50% experience persistent gait impairments characterized by asymmetrical walking patterns, slower walking speed, impaired balance, an…
Phase: NA • Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New pill aims to slow kidney disease in IgA nephropathy patients
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo controlled Phase IIb study to explore the efficacy and safety of STL303 capsules in IgAN patients. About 15 patients dignosed with primary IgAN will be enrolled and randomized to three cohorts and take different dosage of S…
Phase: PHASE2 • Sponsor: Sitala Bio LTD • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Nerve block may ease pain and speed recovery for kids after hip surgery
Symptom relief Not yet recruitingThis study is a prospective, randomized, double-blind clinical trial. Its aim is to evaluate whether adding a pericapsular nerve group (PENG) block to spinal anesthesia can reduce the inflammatory response after hip surgery in children. Hip surgery in children can cause a strong…
Phase: NA • Sponsor: Poznan University of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Emergency room study tests adrenaline to prevent dangerous blood pressure drops
Disease control Not yet recruitingRapid sequence intubation is commonly performed in the emergency department to secure the airway of critically ill patients. However, blood pressure may decrease during or shortly after intubation because of the patient's underlying illness, the effects of induction medications, …
Phase: PHASE4 • Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can VR games protect your brain from Diabetes-Related memory decline?
Symptom relief Recruiting nowA single-center, prospective, open-label, parallel-group randomized controlled trial is conducted to investigate the cognitive-protective efficacy of a novel, diabetes-specific virtual reality (VR)-based cognitive training system integrated with diet management modules, relative …
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New Parkinson's drug MF1 enters first human safety trial
Disease control Recruiting nowThis is a Phase I, investigator-initiated, first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of MF1, a novel agent that is expected to inhibit α-synuclein related pathogenesis in α-synucleinopathies, primarily Parkinson's disease (PD). MF1 aims to ad…
Phase: PHASE1 • Sponsor: University of Shizuoka • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC